Benztropine
Back to searchMolecule Structure
Scientific Name
Benztropine
Description of the Drug
Benzatropine is an anticholinergic drug used to treat Parkinson’s disease (PD) and extrapyramidal symptoms, except tardive dyskinesia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00245
http://www.drugbank.ca/drugs/DB00245
Brand Name(s)
Not Available
Company Owner(s)
Invagen Pharmaceuticals Inc, Aspen Global Inc, Merck And Co Inc, Akorn Operating Co Llc, Vintage Pharmaceuticals Llc, Fresenius Kabi Usa Llc, Upsher Smith Laboratories Llc, Leading Pharma Llc, Epic Pharma Llc, Luitpold Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL35388 | ||
Human Metabolome Database | HMDB0014390 | ||
DrugBank | DB00245 | ||
PubChem: Thomson Pharma | 46492506 | ||
Nikkaji | J232.148C | ||
PDBe | CXQ | ||
BindingDB | 50366775 | ||
EPA CompTox Dashboard | DTXSID9022659 | ||
DrugCentral | 333 | ||
Brenda | 66182 | ||
Guide to Pharmacology | 7601 | ||
rxnorm | BENZTROPINE | BENZTROPINE MESYLATE | COGENTIN |
ChEBI | 3048 | ||
ZINC | ZINC000100036536 |